Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7507482rdf:typepubmed:Citationlld:pubmed
pubmed-article:7507482lifeskim:mentionsumls-concept:C0014442lld:lifeskim
pubmed-article:7507482lifeskim:mentionsumls-concept:C0025519lld:lifeskim
pubmed-article:7507482lifeskim:mentionsumls-concept:C0907533lld:lifeskim
pubmed-article:7507482lifeskim:mentionsumls-concept:C0022702lld:lifeskim
pubmed-article:7507482lifeskim:mentionsumls-concept:C1167622lld:lifeskim
pubmed-article:7507482lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:7507482pubmed:issue3lld:pubmed
pubmed-article:7507482pubmed:dateCreated1994-2-25lld:pubmed
pubmed-article:7507482pubmed:abstractTextNitric oxide (NO) is synthesized from L-arginine by different NO synthase isozymes, which are inhibited by the substrate analogs NG-methyl- and NG-nitro-L-arginine. We studied binding of 3H-labeled NG-nitro-L-arginine to purified brain NO synthase and compared the data with results obtained in enzyme kinetic experiments. Binding data revealed a single binding site for NG-nitro-L-[3H]arginine (KD = 0.17 microM). Binding was competitively antagonized by L-arginine (KI = 2.9 microM). The half-time of dissociation was remarkably slow (9.4 min) and closely correlated with the time necessary for surmounting NO synthase inhibition by dilution. Although an apparently less potent inhibitor, NG-methyl-L-arginine exhibited the same affinity for brain NO synthase as the nitro derivative (KI = 0.17 microM), and in initial rate experiments, almost equal KI values were obtained for NG-methyl-L-arginine (0.61 microM) and NG-nitro-L-arginine (0.53 microM). However, after prolonged incubation periods, NG-nitro-L-arginine induced a rapid inactivation of the enzyme, whereas the methyl derivative turned out to be a substrate of NO synthase, which was slowly converted into stoichiometric amounts of NO and L-citrulline.lld:pubmed
pubmed-article:7507482pubmed:languageenglld:pubmed
pubmed-article:7507482pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7507482pubmed:citationSubsetIMlld:pubmed
pubmed-article:7507482pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7507482pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7507482pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7507482pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7507482pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7507482pubmed:statusMEDLINElld:pubmed
pubmed-article:7507482pubmed:monthJanlld:pubmed
pubmed-article:7507482pubmed:issn0021-9258lld:pubmed
pubmed-article:7507482pubmed:authorpubmed-author:SchmidtKKlld:pubmed
pubmed-article:7507482pubmed:authorpubmed-author:MayerBBlld:pubmed
pubmed-article:7507482pubmed:authorpubmed-author:BrunnerFFlld:pubmed
pubmed-article:7507482pubmed:authorpubmed-author:KlattPPlld:pubmed
pubmed-article:7507482pubmed:issnTypePrintlld:pubmed
pubmed-article:7507482pubmed:day21lld:pubmed
pubmed-article:7507482pubmed:volume269lld:pubmed
pubmed-article:7507482pubmed:ownerNLMlld:pubmed
pubmed-article:7507482pubmed:authorsCompleteYlld:pubmed
pubmed-article:7507482pubmed:pagination1674-80lld:pubmed
pubmed-article:7507482pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7507482pubmed:meshHeadingpubmed-meshheading:7507482-...lld:pubmed
pubmed-article:7507482pubmed:meshHeadingpubmed-meshheading:7507482-...lld:pubmed
pubmed-article:7507482pubmed:meshHeadingpubmed-meshheading:7507482-...lld:pubmed
pubmed-article:7507482pubmed:meshHeadingpubmed-meshheading:7507482-...lld:pubmed
pubmed-article:7507482pubmed:meshHeadingpubmed-meshheading:7507482-...lld:pubmed
pubmed-article:7507482pubmed:meshHeadingpubmed-meshheading:7507482-...lld:pubmed
pubmed-article:7507482pubmed:meshHeadingpubmed-meshheading:7507482-...lld:pubmed
pubmed-article:7507482pubmed:meshHeadingpubmed-meshheading:7507482-...lld:pubmed
pubmed-article:7507482pubmed:meshHeadingpubmed-meshheading:7507482-...lld:pubmed
pubmed-article:7507482pubmed:meshHeadingpubmed-meshheading:7507482-...lld:pubmed
pubmed-article:7507482pubmed:meshHeadingpubmed-meshheading:7507482-...lld:pubmed
pubmed-article:7507482pubmed:year1994lld:pubmed
pubmed-article:7507482pubmed:articleTitleInhibitors of brain nitric oxide synthase. Binding kinetics, metabolism, and enzyme inactivation.lld:pubmed
pubmed-article:7507482pubmed:affiliationInstitut für Pharmakologie und Toxikologie, Karl-Franzens-Universität Graz, Austria.lld:pubmed
pubmed-article:7507482pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7507482pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507482lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507482lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507482lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507482lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507482lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507482lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507482lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507482lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507482lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507482lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507482lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7507482lld:pubmed